study stat - Robuta Search

https://www.statnews.com/2025/11/08/crispr-therapeutics-cholesterol-lowering-gene-editing-study/ CRISPR gene editing therapy cuts LDL cholesterol in small study | STAT Researchers are excited about CRISPR Therapeutics drug's potential to prevent heart attacks with gene editing, but say more safety data needed crispr gene editing therapy cuts ldl cholesterol study stat small https://www.statnews.com/2025/06/23/glp-1-drug-helped-type-1-diabetes-patients-keep-healthy-glucose-levels-and-lose-weight/ GLP-1 drugs effective for type 1 diabetes in new study| STAT Jun 24, 2025 - Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight. glp 1 drugs type diabetes new study effective stat https://www.statnews.com/2026/02/17/ocular-therapeutix-axpaxli-wet-amd-treatment-compared-to-eylea-regeneron/ Ocular Therapeutix wet AMD drug Axpaxli tops Eylea in study | STAT Feb 17, 2026 - Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question. ocular therapeutix wet amd study stat drug tops https://www.statnews.com/2026/03/30/biotech-news-biogen-lupus-drug-improves-skin-clearance-in-trial/ Biogen lupus drug improves skin clearance in mid-stage study | STAT Mar 30, 2026 - Today's biotech news covers a positive mid-stage study for Biogen lupus drug, Takeda's competitive Phase 3 psoriasis data, and more. mid stage study stat biogen lupus drug https://www.statnews.com/2025/06/05/glp-1-drugs-low-but-elevated-risk-of-age-related-macular-degeneration/ GLP-1 drugs may be linked to higher risk of eye disease: study | STAT Jun 6, 2025 - A study of people with diabetes found the risk of macular degeneration remained low, but was 0.2% in people taking GLP-1s, 0.1% in those who didn't. glp 1 drugs higher risk eye disease study stat may https://www.statnews.com/2026/03/23/lyme-disease-vaccine-study-results-efficacy/ Lyme disease vaccine reduces risk by more than 70% in study | STAT Mar 23, 2026 - Though a vaccine from Pfizer and Valneva missed its primary endpoint, it still represents hope in fight to prevent Lyme disease. lyme disease vaccine reduces risk study stat 70 https://www.statnews.com/2026/04/01/ai-ambient-scribes-modest-time-savings-clinical-documentation/ Large AI scribe study finds modest time savings, inconsistent use | STAT Apr 2, 2026 - Using AI scribes for clinical documentation saved doctors, across five academic medical centers, about 16 minutes per eight hours of patient care, a new study... large ai study finds time savings scribe modest https://www.statnews.com/2026/03/23/insmed-mac-lung-infection-arikayce-results/ Insmed's Arikayce benefits patients with MAC lung infection, study shows | STAT Mar 23, 2026 - Insmed Arikayce study showing benefit to patients with rare lung disease could lead to expanded approval, higher sales. lung infection study shows insmed benefits patients https://www.statnews.com/2026/04/07/genomic-tests-needed-for-targeted-cancer-treatments/ Study finds missed opportunities for targeted cancer treatments | STAT Apr 13, 2026 - Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival. targeted cancer treatments study finds missed opportunities stat https://www.statnews.com/2026/03/19/biotech-uses-apple-watch-parkinsons-drug-study-health-tech/ STAT Health Tech: A biotech turns to Apple Watch to study its Parkinson's drug Mar 19, 2026 - In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and some insights into how physicians are using... stat health tech apple watch biotech turns study https://www.statnews.com/2026/03/09/bcbs-study-hospitals-use-ai-upcoding-drive-up-prices/ Blue Cross Blue Shield study says AI upcoding is driving up prices | STAT A new BCBS data analysis claims that AI coding tools used by hospitals are driving up medical bills, raising concerns about the affordability of health care. blue cross shield study says ai driving prices https://www.statnews.com/2026/02/19/grail-cancer-test-galleri-results/ Key study of Grail’s cancer detection test fails in setback for company | STAT Feb 20, 2026 - While Grail's screening test, called Galleri, showed some benefits, the results are likely to fuel more debate about the technology. key study cancer detection test fails setback